Tufts University

tufts.edu

Total trials

222

Active

27

Phase 3

5

Total enrollment

495,028

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 6 of 6 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Acellular Dermal Matrix1
1000 ppm F toothpaste1
Anesthetic spray1
Masking Tape1
d-PTFE1
Ti-mesh1

Next readouts

  • 2018-03
  • 2025-09
  • 2027-12-01
  • 2027-12-07

Top conditions

  • Obesity12
  • Cardiovascular Diseases11
  • Healthy9
  • Sarcopenia9
  • Heart Diseases7
  • Telehealth6
  • Dietary Intake6
  • WIC6

Frequently asked questions about Tufts University

How many clinical trials does Tufts University have on ClinicalTrials.gov?
Tufts University is listed as the lead sponsor on 222 clinical trials in ClinicalTrials.gov, 27 of which are currently active (recruiting, enrolling, or ongoing).
How many of Tufts University's trials are in Phase 3?
5 of Tufts University's trials are in Phase 3, spread across 6 active drug programs.
What therapeutic areas does Tufts University focus on?
Tufts University's most-studied conditions on ClinicalTrials.gov are Obesity, Cardiovascular Diseases, Healthy, Sarcopenia, Heart Diseases.
When are Tufts University's next clinical trial readouts?
Tufts University has 4 upcoming primary-completion readouts tracked here; the soonest is “Comparing the Efficacy and Morbidity of Two Vertical Ridge Augmentation Techniques”, expected around 2018-03.